MIM
Marco Investment Management Portfolio holdings
AUM
$1.2B
This Quarter Return
+14.3%
1 Year Return
+22.28%
3 Year Return
+87.03%
5 Year Return
+157.96%
10 Year Return
+313.92%
AUM
$697M
AUM Growth
+$697M
(+14%)
Cap. Flow
+$10.5M
Cap. Flow
% of AUM
1.5%
Top 10 Holdings %
Top 10 Hldgs %
31.77%
Holding
194
New
19
Increased
54
Reduced
72
Closed
4
Top Buys
| 1 |
Illumina
ILMN
|
$4.63M |
| 2 |
Marvell Technology
MRVL
|
$4.28M |
| 3 |
Amgen
AMGN
|
$3.5M |
| 4 |
AbbVie
ABBV
|
$2.39M |
| 5 |
Union Pacific
UNP
|
$2.19M |
Top Sells
| 1 |
CVS Health
CVS
|
$3.25M |
| 2 |
Match Group
MTCH
|
$2.43M |
| 3 |
L3Harris
LHX
|
$2.32M |
| 4 |
Intel
INTC
|
$2.09M |
| 5 |
IAC Inc
IAC
|
$1.41M |
Sector Composition
| 1 | Technology | 27.19% |
| 2 | Healthcare | 19% |
| 3 | Financials | 10.25% |
| 4 | Industrials | 9.74% |
| 5 | Consumer Staples | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Enterprise Products Partners
EPD
$69.4B
| $8.22M | 1.18% |
419,566
+3,400
| +0.8% | +$66.6K |
|
27
Abbott
ABT
$230B
| $7.83M | 1.12% |
71,487
-399
| -0.6% | -$43.7K |
|
28
Procter & Gamble
PG
$369B
| $7.75M | 1.11% |
55,717
-2,780
| -5% | -$387K |
|
29
NXP Semiconductors
NXPI
$57.8B
| $7.66M | 1.1% |
48,195
+4,080
| +9% | +$649K |
|
30
Salesforce
CRM
$242B
| $7.37M | 1.06% |
33,115
+506
| +2% | +$113K |
|
31
American Express
AXP
$226B
| $7.34M | 1.05% |
60,709
+4,150
| +7% | +$502K |
|
32
Walmart
WMT
$772B
| $7.25M | 1.04% |
50,310
-2,200
| -4% | -$317K |
|
33
Merck
MRK
$212B
| $6.87M | 0.99% |
83,937
+3,900
| +5% | +$319K |
|
34
SPDR S&P 500 ETF Trust
SPY
$651B
| $6.84M | 0.98% |
18,288
-38
| -0.2% | -$14.2K |
|
35
Exact Sciences
EXAS
$9.14B
| $6.05M | 0.87% |
45,673
-1,165
| -2% | -$154K |
|
36
Alphabet (Google) Class A
GOOGL
$2.52T
| $5.21M | 0.75% |
2,974
-93
| -3% | -$163K |
|
37
Honeywell
HON
$137B
| $5.13M | 0.74% |
24,121
+475
| +2% | +$101K |
|
38
Oracle
ORCL
$627B
| $5.05M | 0.72% |
78,043
-12,800
| -14% | -$828K |
|
39
iShares Biotechnology ETF
IBB
$5.68B
| $5.02M | 0.72% |
33,134
| – | – |
|
|
40
L3Harris
LHX
$51.7B
| $4.88M | 0.7% |
25,840
-12,300
| -32% | -$2.32M |
|
41
Johnson & Johnson
JNJ
$428B
| $4.85M | 0.7% |
30,810
+601
| +2% | +$94.6K |
|
42
Duke Energy
DUK
$94.9B
| $4.81M | 0.69% |
52,493
-1,480
| -3% | -$136K |
|
43
Pfizer
PFE
$142B
| $4.72M | 0.68% |
128,284
+4,309
| +3% | +$159K |
|
|
44
Illumina
ILMN
$15.3B
| $4.63M | 0.66% |
+12,500
| New | +$4.63M |
|
45
Gilead Sciences
GILD
$140B
| $4.59M | 0.66% |
78,746
-5,098
| -6% | -$297K |
|
46
Aflac
AFL
$56.5B
| $4.35M | 0.62% |
97,840
+150
| +0.2% | +$6.67K |
|
|
47
Marvell Technology
MRVL
$54.4B
| $4.28M | 0.61% |
+90,000
| New | +$4.28M |
|
48
Northrop Grumman
NOC
$84B
| $4.19M | 0.6% |
13,749
+2,325
| +20% | +$709K |
|
49
Meta Platforms (Facebook)
META
$1.84T
| $4.06M | 0.58% |
14,872
-525
| -3% | -$143K |
|
50
Charles Schwab
SCHW
$172B
| $3.82M | 0.55% |
71,966
-1,000
| -1% | -$53K |
|